Purification of nanoparticle suspensions by a concentration/diafiltration process

被引:64
作者
Limayem, I [1 ]
Charcosset, C [1 ]
Fessi, H [1 ]
机构
[1] UCB Lyon 1, UMR CNRS 5007, Lab Automat & Genie Proc LAGEP, CPE Lyon, F-69622 Villeurbanne, France
关键词
concentration; diafiltration; nanocapsule; nanoparticle; purification;
D O I
10.1016/j.seppur.2003.10.002
中图分类号
TQ [化学工业];
学科分类号
0817 [化学工程与技术];
摘要
Nanoparticles are solid colloidal particles ranging in size from about 10-1000 nm. Depending on the method of preparation, the following potentially toxic impurities can be present in the nanoparticulate suspensions: organic solvents, surfactants, residual monomers, polymerization initiators and large polymer aggregates. The potential use of nanoparticles in an oral or parenteral route implies an intensive purification. In the present work, we investigated the purification by crossflow microfiltration of nanoparticulate suspensions prepared by an emulsion-diffusion technique. The purification process involved two steps, first a concentration step where the preparation is concentrated by a factor of 115, then a diafiltration step, where the feed volume is kept constant by adding continuously pure water. It was shown that polyvinyl alcohol (PVAL) and ethyl acetate concentrations decreased to an acceptable level, after 40 min of concentration and 2 It of diafiltration. The nanoparticulate suspension remained stable after 9 weeks of storage. Indomethacin loaded nanocapsules were purified without loss of drug efficiency. Also, the influence of process parameters as crossflow flowrate on the PVAL amount present in the feed was investigated. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 17 条
[1]
MECHANISMS OF PERMEATE FLUX DECAY, SOLUTE REJECTION AND CONCENTRATION POLARIZATION IN CROSS-FLOW FILTRATION OF A DOUBLE-CHAIN IONIC SURFACTANT DISPERSION [J].
AKAY, G ;
WAKEMAN, RJ .
JOURNAL OF MEMBRANE SCIENCE, 1994, 88 (2-3) :177-195
[2]
Al Khouri F, 1986, INT J PHARMACEUT, V28, P125
[3]
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
[4]
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P13
[5]
OPTIMIZING PROCESS TIME FOR ULTRAFILTRATION AND DIAFILTRATION [J].
ASBI, BA ;
CHERYAN, M .
DESALINATION, 1992, 86 (01) :49-62
[6]
SEPARATION OF DRUG-LOADED NANOPARTICLES FROM FREE DRUG BY GEL-FILTRATION [J].
BECK, P ;
SCHERER, D ;
KREUTER, J .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (04) :491-496
[7]
MACROSOLUTE-MICROSOLUTE SEPARATION BY ULTRA-FILTRATION - A REVIEW OF DIAFILTRATION PROCESSES AND APPLICATIONS [J].
DUTRE, B ;
TRAGARDH, G .
DESALINATION, 1994, 95 (03) :227-267
[8]
THE INFLUENCE OF SURFACTANT ON WATER FLUX THROUGH MICROFILTRATION MEMBRANES [J].
FIELD, R ;
HANG, S ;
ARNOT, T .
JOURNAL OF MEMBRANE SCIENCE, 1994, 86 (03) :291-304
[9]
THE INFLUENCE OF NONIONIC AND IONIC SURFACTANTS ON HYDROPHOBIC AND HYDROPHILIC ULTRAFILTRATION MEMBRANES [J].
JONSSON, AS ;
JONSSON, B .
JOURNAL OF MEMBRANE SCIENCE, 1991, 56 (01) :49-76
[10]
INTERFACIAL POLYMERIZATION, A USEFUL METHOD FOR THE PREPARATION OF POLYMETHYLCYANOACRYLATE NANOPARTICLES [J].
KRAUSE, HJ ;
SCHWARZ, A ;
ROHDEWALD, P .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (04) :527-552